SCHEMBL2073758

SCHEMBL2073758

C=C(C)CN(Cc1ccccc1)CC(C)(C)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.39
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TSHR P16473 1/20 0.37
RECQL P46063 1/20 0.37
CNR2 P34972 1/20 0.37
LMNA P02545 1/20 0.37
RIPK1 Q13546 2/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP13 P45452 1/20 0.36
NOS2 P35228 1/20 0.36
G6PC1 P35575 1/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
AOC3 Q16853 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10246603 0.84 ALDH1A1 (0.46) ALDH1A1TSHRCNR2LMNAG6PC1
SCHEMBL2518042 0.84 ALDH1A1 (0.46) RORCALDH1A1TSHRCNR2RIPK1
SCHEMBL2015197 0.82 RIPK1 (0.44) RORCRECQLLMNARIPK1MMP1
SCHEMBL12842010 0.81 ALDH1A1 (0.43) ALDH1A1TSHRCNR2LMNAG6PC1
SCHEMBL2073073 0.77 HTT (0.50) ALDH1A1TSHRCNR2LMNAG6PC1
SCHEMBL2050631 0.75 ALDH1A1 (0.45) ALDH1A1TSHRLMNARIPK1MEN1
SCHEMBL25909666 0.74 KDM4E (0.37) ALDH1A1TSHRCNR2LMNAG6PC1
SCHEMBL9210778 0.74 LMNA (0.40) ALDH1A1TSHRCNR2LMNAMEN1
SCHEMBL21905878 0.73 CYP1A2 (0.50) ALDH1A1L3MBTL1
SCHEMBL10246599 0.72 ALDH1A1 (0.50) ALDH1A1TSHRLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12011490-B2 Dental photocurable composition excellent in operability and storage stability SHOFU INC. (JP) 2024-06-18 US disclosed
US-20220401312-A1 DENTAL PHOTOCURABLE COMPOSITION EXCELLENT IN OPERABILITY AND STORAGE STABILITY SHOFU INC. (JP) 2022-12-22 US disclosed
EP-4062895-A1 DENTAL PHOTOCURABLE COMPOSITION EXCELLENT IN OPERABILITY AND STORAGE STABILITY Shofu Inc. (JP) 2022-09-28 EP disclosed
CN-115068345-A Dental adhesive composition having excellent storage stability 株式会社松风 2022-09-20 CN disclosed
CN-115068346-A Dental photocurable composition having excellent handling properties and storage stability 株式会社松风 2022-09-20 CN disclosed
US-20220287918-A1 DENTAL ADHESIVE COMPOSITION EXCELLENT IN STORAGE STABILITY SHOFU INC. (JP) 2022-09-15 US disclosed
EP-4056163-A1 DENTAL ADHESIVE COMPOSITION EXCELLENT IN STORAGE STABILITY Shofu Inc. (JP) 2022-09-14 EP disclosed
US-7902356-B2 Thiazolopyridinone derivates as MCH receptor antagonists ELI LILLY AND COMPANY (US) 2011-03-08 US disclosed
US-7902356-B2 Thiazolopyridinone derivates as MCH receptor antagonists ELI LILLY AND COMPANY (US) 2011-03-08 US disclosed
EP-1828207-B1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2009-10-28 EP disclosed
EP-1828207-B1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2009-10-28 EP disclosed
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2009-09-17 US disclosed
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY 2009-09-17 US disclosed
EP-1828207-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2007-09-05 EP disclosed
WO-2006066174-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12011490-B2 Dental photocurable composition excellent in operability and storage stability H1-0, CCND1, CCNT1 RORC 3938/4885CTSS 651/4885CTSK 1695/4885
US-20090233919-A1 THIAZOLOPYRIDINONE DERIVATES AS MCH RECEPTOR ANTAGONISTS MCHR1, MCHR2, MC1R RORC 144/4885CTSS 4456/4885CTSK 4273/4885
US-20220287918-A1 DENTAL ADHESIVE COMPOSITION EXCELLENT IN STORAGE STABILITY ITGA1, ITGB1, CDH1 RORC 3920/4885CTSS 3387/4885CTSK 4238/4885
US-20220401312-A1 DENTAL PHOTOCURABLE COMPOSITION EXCELLENT IN OPERABILITY AND STORAGE STABILITY H1-0, CCND1, CCNT1 RORC 3922/4885CTSS 638/4885CTSK 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.